Global Radiation Oncology Market Overview:
Global Radiation Oncology Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Radiation Oncology Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Radiation Oncology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Radiation Oncology Market:
The Radiation Oncology Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Radiation Oncology Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Radiation Oncology Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Radiation Oncology market has been segmented into:
External Beam Radiation Therapy and Internal Radiation Therapy
By Application, Radiation Oncology market has been segmented into:
Prostate Cancer
Breast Cancer
Lung Cancer
Head & Neck
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Radiation Oncology market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Radiation Oncology market.
Top Key Players Covered in Radiation Oncology market are:
Varian Medical Systems
Inc. (US)
Elekta (Sweden)
Accuracy Incorporated. (US)
IBA Radiopharma Solutions (Belgium)
BD (US)
Mevion Medical Systems (US)
Nordion (Canada)
NTP Radioisotopes Soc Ltd. (South Africa)
Curium (France)
Reflexion (US)
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Radiation Oncology Market Type
4.1 Radiation Oncology Market Snapshot and Growth Engine
4.2 Radiation Oncology Market Overview
4.3 External Beam Radiation Therapy and Internal Radiation Therapy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 External Beam Radiation Therapy and Internal Radiation Therapy: Geographic Segmentation Analysis
Chapter 5: Radiation Oncology Market Application
5.1 Radiation Oncology Market Snapshot and Growth Engine
5.2 Radiation Oncology Market Overview
5.3 Prostate Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Prostate Cancer: Geographic Segmentation Analysis
5.4 Breast Cancer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Breast Cancer: Geographic Segmentation Analysis
5.5 Lung Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Lung Cancer: Geographic Segmentation Analysis
5.6 Head & Neck
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Head & Neck: Geographic Segmentation Analysis
5.7 and Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Radiation Oncology Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 VARIAN MEDICAL SYSTEMS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC. (US)
6.4 ELEKTA (SWEDEN)
6.5 ACCURACY INCORPORATED. (US)
6.6 IBA RADIOPHARMA SOLUTIONS (BELGIUM)
6.7 BD (US)
6.8 MEVION MEDICAL SYSTEMS (US)
6.9 NORDION (CANADA)
6.10 NTP RADIOISOTOPES SOC LTD. (SOUTH AFRICA)
6.11 CURIUM (FRANCE)
6.12 REFLEXION (US)
Chapter 7: Global Radiation Oncology Market By Region
7.1 Overview
7.2. North America Radiation Oncology Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 External Beam Radiation Therapy and Internal Radiation Therapy
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Prostate Cancer
7.2.3.2 Breast Cancer
7.2.3.3 Lung Cancer
7.2.3.4 Head & Neck
7.2.3.5 and Others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Radiation Oncology Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 External Beam Radiation Therapy and Internal Radiation Therapy
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Prostate Cancer
7.3.3.2 Breast Cancer
7.3.3.3 Lung Cancer
7.3.3.4 Head & Neck
7.3.3.5 and Others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Radiation Oncology Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 External Beam Radiation Therapy and Internal Radiation Therapy
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Prostate Cancer
7.4.3.2 Breast Cancer
7.4.3.3 Lung Cancer
7.4.3.4 Head & Neck
7.4.3.5 and Others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Radiation Oncology Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 External Beam Radiation Therapy and Internal Radiation Therapy
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Prostate Cancer
7.5.3.2 Breast Cancer
7.5.3.3 Lung Cancer
7.5.3.4 Head & Neck
7.5.3.5 and Others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Radiation Oncology Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 External Beam Radiation Therapy and Internal Radiation Therapy
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Prostate Cancer
7.6.3.2 Breast Cancer
7.6.3.3 Lung Cancer
7.6.3.4 Head & Neck
7.6.3.5 and Others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Radiation Oncology Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 External Beam Radiation Therapy and Internal Radiation Therapy
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Prostate Cancer
7.7.3.2 Breast Cancer
7.7.3.3 Lung Cancer
7.7.3.4 Head & Neck
7.7.3.5 and Others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Radiation Oncology Scope:
|
Report Data
|
Radiation Oncology Market
|
|
Radiation Oncology Market Size in 2025
|
USD XX million
|
|
Radiation Oncology CAGR 2025 - 2032
|
XX%
|
|
Radiation Oncology Base Year
|
2024
|
|
Radiation Oncology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuracy Incorporated. (US), IBA Radiopharma Solutions (Belgium), BD (US), Mevion Medical Systems (US), Nordion (Canada), NTP Radioisotopes Soc Ltd. (South Africa), Curium (France), Reflexion (US).
|
|
Key Segments
|
By Type
External Beam Radiation Therapy and Internal Radiation Therapy
By Applications
Prostate Cancer
Breast Cancer
Lung Cancer
Head & Neck
and Others
|
